GC
Trafalgar International, Inc.
GCAN · OTC
$1.60 +0.00% (+$0.00)
1M +571.43%
Market Cap $318.2K
P/E Ratio 0.36x
Div. Yield -
ROE -
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/E 0.36x
PEG N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
79 /100
Excellent ROA 792,486.00%
Asset turnover 0.00x
ROIC 1,122.60%
Debt
2 /100
High Int. coverage 0.30x
Current ratio 0.01x
Net debt/EBITDA N/A
Stability
36 /100
Moderate Beta 0.34x
EPS volatility N/A
Profitable years N/A
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about GCAN
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Porfirio Sánchez-Talavera
Employees
1
Headquarters
Miami